DiagnosticsValidate
Leptospirosis Test Kit
A dual-target lateral flow (LFIA) test for leptospirosis that detects both antigen and antibody on a single strip, improving the chance of early detection. Suited to community hospitals.
02
The need
Late diagnosis of leptospirosis can lead to severe illness and poor outcomes, especially in endemic areas.
03
The innovation
Detects both antigen and antibody on a single rapid test strip, without needing a laboratory.
04
Development stage
- Explore
- Develop
- Validate
- Market-ready
- Commercial
Field and market feasibility testing has been carried out with Sisaket Hospital and community hospitals.
05
Evidence and results
Focus groups and real-world testing with healthcare staff in Sisaket; users reported that the kit was practical and accurate.
06
Next milestone
Preparing for wider use, licensing and commercialization.
Team
- รศ.พญ.ดร. กนิษฐา ภัทรกุล